SL

Sunny Laxmikant Pandey

Active Director Director DIN 09117930
DIN 09117930 First appointment Mar 2021 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value •••• Premium profile

About Sunny Laxmikant Pandey

Data last updated:

Sunny Laxmikant Pandey is a Director at Oswald Biotech Private Limited (since 2021). The company operates in Trading. Oswald Biotech Private Limited reported revenue of ₹46 Lakh (FY 2025).

DIN 09117930
Primary Designation Director
Industry Trading
First Appointment 22 Mar 2021
Oldest Company Age 5 yrs
Largest company Oswald Biotech Private Limited · ₹46 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Oswald Biotech Private Limited U51909MH2021PTC357593
Director22 Mar 20212021₹46 Lakh (FY 2025)Active

Board colleagues of Sunny Laxmikant Pandey

NameDINCompanyDesignation
Mansi Pradeep Tripathi09117931Oswald Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Oswald Biotech Private Limited
Premium access

Shareholding and investment profile for Sunny Laxmikant Pandey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunny Laxmikant Pandey

Sunny Laxmikant Pandey currently holds 1 directorship: Oswald Biotech Private Limited (Director, since 22 Mar 2021, revenue ₹46 Lakh (FY 2025)).

Sunny Laxmikant Pandey was first appointed on 22 Mar 2021 as Director at Oswald Biotech Private Limited.

The current boards of Sunny Laxmikant Pandey's companies include Mansi Pradeep Tripathi (Oswald Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available